Aroa Biosurgery in trading halt for capital raise

Rebecca Stevenson
Tue, 27 Jul 2021

Aroa Biosurgery in trading halt for capital raise
Aroa has five products approved for sale in the US. (Image: Supplied)
Rebecca Stevenson
Tue, 27 Jul 2021
New Zealand headquartered medical company Aroa will raise capital to boost its presence in the US.The Australian Financial Review reported the company was seeking A$52 million to fund the expansion of its US sales team, as well as research and development.In a June market update, the soft-tissue regeneration company said US medical procedure numbers continued to reflect a positive trend “supporting improved sales momentum”.Aroa has commercial operations based in San Diego and sales professionals across the US. In its 2021 results fo...

Not convinced yet?

Subscribe to our Daily News Update free newsletter.

More work on Onslow gets green light from ministers
Ian Llewellyn | Thu, 07 Jul 2022

Cabinet gives green light to more Onslow pumped hydro project, narrows down alternative options on solving the dry year problem.

Homebuyers: the bank is still watching your spending
Frances Cook | Thu, 07 Jul 2022

The sillier parts of the CCCFA are gone, but banks still need to make sure you can afford a loan, so they’re going to go through your income and expenses. 

Law & Regulation
Lego, Zuru to head to trial over use of trademark
Ben Moore | Thu, 07 Jul 2022

The two toy titans have clashed over Zuru’s use of the Lego trademark on statements of compatibility on its packaging.

How can Kiwi small business owners manage rising inflation?

Xero MD Craig Hudson says small businesses have been hit with a triple whammy.

Digital innovation could shape the future of NZ

The digital age allows us to collaborate on some of our greatest scientific and environmental challenges